Free T4: When to Order This Test

At a glance
- Normal adult free T4 range / 0.8 to 1.8 ng/dL (10 to 23 pmol/L) in most reference labs
- Primary use / Confirms and classifies thyroid dysfunction after an abnormal TSH
- Turnaround time / Results typically available within 24 hours from a standard blood draw
- Fasting required / No; free T4 is not significantly affected by meals
- Best paired with / TSH as a first-line combination for thyroid assessment
- Pregnancy adjustment / Trimester-specific ranges apply; free T4 runs higher in the first trimester
- Medication monitoring / Check 6 to 8 weeks after any levothyroxine dose change
- Cost range / $25, $50 without insurance at most commercial labs
What Free T4 Actually Measures
Free T4 (free thyroxine) represents the 0.02 to 0.03% of total circulating T4 that is not bound to transport proteins like thyroxine-binding globulin (TBG), albumin, or transthyretin [1]. This tiny unbound fraction is the only portion available to enter cells and drive metabolic activity. Total T4 tests, by contrast, reflect both bound and unbound hormone, making them vulnerable to distortion by changes in binding-protein levels.
Why "Free" Matters More Than "Total"
Estrogen therapy, pregnancy, liver disease, and genetic TBG variants all shift total T4 without changing the hormone available to tissues [2]. A woman on oral contraceptives may show an elevated total T4 yet have a perfectly normal free T4. The American Thyroid Association (ATA) recommends free T4 over total T4 for this reason, stating that "measurement of serum free T4 is preferred over total T4 for the assessment of thyroid hormone levels" [3].
The TSH, Free T4 Relationship
TSH and free T4 exist in a log-linear inverse relationship. Small changes in free T4 produce large swings in TSH. A 20% drop in free T4 can cause TSH to double or triple [4]. This amplification effect is why TSH screening catches thyroid dysfunction early, but free T4 is needed to confirm severity and guide treatment.
When Clinicians Should Order Free T4
A free T4 test is not a screening test for the general population. TSH alone fills that role in most adults. Free T4 earns its place in specific clinical scenarios where TSH is abnormal, unreliable, or insufficient.
Abnormal TSH Confirmation
The most common trigger for ordering free T4 is an abnormal TSH result. The American Association of Clinical Endocrinology (AACE) and the ATA both recommend measuring free T4 whenever TSH falls outside the reference range [5]. An elevated TSH paired with a low free T4 confirms primary hypothyroidism. An elevated TSH with a normal free T4 defines subclinical hypothyroidism, a distinction that changes the treatment decision entirely.
Suspected Hyperthyroidism
Suppressed TSH (<0.1 mIU/L) with elevated free T4 confirms overt hyperthyroidism. In Graves' disease, free T4 levels frequently exceed 3.0 ng/dL at diagnosis [6]. Free T3 may also be ordered alongside free T4 in suspected hyperthyroidism because some patients present with T3-predominant thyrotoxicosis where free T4 remains normal.
Thyroid Medication Monitoring
Patients taking levothyroxine, liothyronine, or desiccated thyroid need periodic free T4 checks. The ATA recommends measuring TSH and free T4 six to eight weeks after any dose adjustment [3]. For patients on combination T4/T3 therapy, the timing of blood draw relative to the last liothyronine dose matters: draw before the morning dose or at least 4 hours after to avoid a transient free T3 spike that can confuse interpretation.
Pregnancy
Thyroid physiology shifts dramatically during pregnancy. Human chorionic gonadotropin (hCG) stimulates the TSH receptor in the first trimester, suppressing TSH and raising free T4 physiologically [7]. The ATA recommends trimester-specific reference ranges and states that "TSH should be measured at the first prenatal visit, with free T4 measurement when TSH is abnormal" [8]. Standard non-pregnant reference ranges cannot be applied to pregnant patients. Most laboratories report first-trimester free T4 upper limits approximately 50% higher than non-pregnant values.
Pituitary or Hypothalamic Disease
TSH becomes unreliable when the pituitary gland itself is damaged. In central hypothyroidism (secondary or tertiary), TSH may be low, normal, or even mildly elevated despite inadequate thyroid hormone production [9]. Free T4 is the primary monitoring tool in these patients. The Endocrine Society recommends targeting free T4 in the upper half of the reference range for patients with central hypothyroidism on levothyroxine [10].
How to Interpret Free T4 Results
Reading a free T4 value in isolation tells you very little. The result only becomes clinically meaningful when paired with TSH and the patient's clinical picture.
Normal Free T4 Range
Most commercial labs report a reference interval of 0.8 to 1.8 ng/dL (10 to 23 pmol/L) for non-pregnant adults [11]. The NHANES III survey found that the median free T4 in the U.S. Adult population was approximately 1.3 ng/dL, with values declining slightly with age [12]. Assay variability between laboratories can reach 15 to 20%, so trending results over time within the same lab produces more reliable data than comparing values across different platforms.
High Free T4
A free T4 above the reference range, combined with suppressed TSH, points toward hyperthyroidism. Common causes include Graves' disease, toxic multinodular goiter, thyroiditis, and excessive thyroid hormone ingestion. In a study of 1,284 patients with newly diagnosed Graves' disease, the mean free T4 at presentation was 3.8 ng/dL [6]. Free T4 also rises transiently in non-thyroidal illness (the "sick euthyroid" state), during acute psychiatric admissions, and with certain medications including amiodarone and high-dose biotin supplements.
Biotin interference deserves particular attention. The FDA issued a safety communication in 2017 warning that biotin in doses above 5 mg/day can cause falsely elevated free T4 results on streptavidin-biotin immunoassays [13]. Patients should stop biotin supplements at least 48 hours before thyroid testing.
Low Free T4
Low free T4 with elevated TSH defines overt primary hypothyroidism. The Colorado Thyroid Disease Prevalence Study (N=25,862) found that 9.5% of participants had elevated TSH, while 0.3% had overt hypothyroidism with both elevated TSH and low free T4 [14]. Low free T4 with normal or low TSH suggests central hypothyroidism and warrants pituitary imaging.
How to Lower Free T4
Free T4 that is too high usually reflects overproduction by the thyroid gland or overreplacement with thyroid medication.
Medication Adjustment
For patients on levothyroxine whose free T4 runs above range, the fix is straightforward: reduce the dose. Guidelines recommend decreasing by 12.5 to 25 mcg increments, rechecking in 6 to 8 weeks [3]. Over-replaced patients face increased risk of atrial fibrillation. A Danish population-based study (N=586,460) demonstrated that even mildly suppressed TSH from excess levothyroxine carried a 1.6-fold increased risk of atrial fibrillation over 7 years [15].
Antithyroid Drugs
In hyperthyroidism caused by Graves' disease or toxic nodular goiter, methimazole is the first-line treatment in the United States. The ATA recommends starting methimazole at 10 to 30 mg daily for moderate-to-severe Graves' hyperthyroidism, with free T4 checks every 4 to 6 weeks until levels normalize [16]. Dr. David Cooper, former president of the ATA, has noted that "methimazole is preferred over propylthiouracil in nearly all non-pregnant adults because of its longer half-life and lower hepatotoxicity risk" [16].
Radioactive Iodine and Surgery
When antithyroid drugs fail or are contraindicated, radioactive iodine ablation or thyroidectomy can permanently lower thyroid hormone production. Both approaches convert the problem from hyperthyroidism to managed hypothyroidism requiring lifelong levothyroxine replacement.
How to Raise Free T4
Low free T4 most commonly reflects an underactive thyroid gland or inadequate replacement dosing.
Levothyroxine Therapy
Levothyroxine remains the standard of care for hypothyroidism. The ATA recommends a full replacement dose of 1.6 mcg/kg/day for complete thyroid failure, though most patients with partial function require less [3]. Absorption matters: levothyroxine should be taken on an empty stomach, 30 to 60 minutes before breakfast or at bedtime (at least 3 hours after the last meal). Calcium supplements, iron, and proton pump inhibitors reduce absorption and should be separated by at least 4 hours.
Addressing Absorption Barriers
Patients whose free T4 remains low despite adequate dosing may have malabsorption from celiac disease, gastric bypass, or concurrent medications. A study of 68 patients with refractory hypothyroidism found that 21% had undiagnosed celiac disease confirmed by duodenal biopsy [17]. Switching to liquid levothyroxine or soft-gel capsules (such as Tirosint) can bypass some absorption issues related to gastric pH.
Lifestyle Factors
No food or supplement reliably raises free T4 in a clinically meaningful way. Selenium (200 mcg/day) has shown benefit in autoimmune thyroiditis by reducing TPO antibodies, but its effect on free T4 levels is modest at best [18]. Iodine supplementation only helps if the patient is iodine-deficient, which is uncommon in the United States due to iodized salt. Excess iodine can paradoxically worsen thyroid function in susceptible individuals through the Wolff-Chaikoff effect.
Special Populations and Testing Considerations
Free T4 interpretation requires adjustment in several clinical contexts where standard ranges do not apply.
Older Adults
The NHANES III data showed that TSH distributions shift upward with age, meaning that a TSH of 6.0 mIU/L may be physiologically normal in an 80-year-old [12]. Free T4 tends to decline slightly with aging. The Endocrine Society advises caution in treating subclinical hypothyroidism in adults over 70, recommending against routine treatment when TSH is below 10 mIU/L and free T4 is normal [10].
Critical Illness
Seriously ill hospitalized patients often display low free T4 with low or normal TSH, a pattern called non-thyroidal illness syndrome (NTIS). This does not represent true hypothyroidism. A meta-analysis of 14 studies (N=1,591 ICU patients) found that thyroid hormone replacement in NTIS did not improve mortality [19]. The AACE recommends deferring thyroid testing in acutely ill patients unless there is strong clinical suspicion of thyroid storm or myxedema coma [5].
Neonatal Screening
Congenital hypothyroidism affects approximately 1 in 2,000 to 4,000 newborns worldwide [20]. Most U.S. Newborn screening programs measure TSH from a heel-prick blood spot, with confirmatory free T4 testing performed when TSH is elevated. Early detection and treatment within 14 days of birth prevents intellectual disability.
Ordering Logistics and Practical Tips
Ordering a free T4 test is simple, but a few practical details affect result quality.
Timing and Preparation
No fasting is required. Free T4 shows minimal diurnal variation, unlike cortisol or testosterone, so time-of-day is not a major concern. For patients on levothyroxine, draw blood before the morning dose. Taking levothyroxine immediately before the blood draw can transiently spike free T4 by 15 to 20% and mislead clinical decisions [21].
How Often to Retest
After a new thyroid diagnosis: recheck TSH and free T4 every 6 to 8 weeks until stable. Once euthyroid on a stable dose: annual TSH with free T4 only if TSH is abnormal. During pregnancy: each trimester, or more frequently if adjusting medication. On amiodarone therapy: every 3 to 6 months due to the drug's complex effects on thyroid metabolism [22].
Ordering Alongside Other Thyroid Tests
A reasonable initial thyroid panel includes TSH and free T4. Add free T3 if hyperthyroidism is suspected. Add TPO antibodies if you want to confirm Hashimoto's thyroiditis as the cause of hypothyroidism. Thyroglobulin and thyroglobulin antibodies are reserved for thyroid cancer monitoring, not routine thyroid function testing.
Patients starting levothyroxine after thyroidectomy for differentiated thyroid cancer should have free T4 checked alongside TSH to ensure adequate suppression, with targets varying by recurrence risk category per ATA 2015 guidelines [23].
Frequently asked questions
›What is a normal Free T4 level?
›What does a high Free T4 mean?
›What does a low Free T4 mean?
›Do I need to fast before a Free T4 test?
›How often should I get my Free T4 checked?
›Can biotin supplements affect my Free T4 results?
›Is Free T4 the same as Total T4?
›What is the difference between Free T4 and Free T3?
›Can stress affect Free T4 levels?
›Should I order Free T4 or TSH first?
›What medications can interfere with Free T4 levels?
›Does Free T4 change during pregnancy?
References
- Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989;10(3):232-274. https://pubmed.ncbi.nlm.nih.gov/2673754/
- Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987;65(4):689-696. https://pubmed.ncbi.nlm.nih.gov/3116030/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Spencer CA, LoPresti JS, Patel A, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990;70(2):453-460. https://pubmed.ncbi.nlm.nih.gov/2298859/
- Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: a joint statement from the AACE, ATA, and the Endocrine Society. J Clin Endocrinol Metab. 2005;90(1):581-585. https://pubmed.ncbi.nlm.nih.gov/15643019/
- Burch HB, Cooper DS. Management of Graves disease: a review. JAMA. 2015;314(23):2544-2554. https://jamanetwork.com/journals/jama/fullarticle/2481005
- Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404-433. https://pubmed.ncbi.nlm.nih.gov/9183570/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/
- Persani L. Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab. 2012;97(9):3068-3078. https://pubmed.ncbi.nlm.nih.gov/22851492/
- Fleseriu M, Hashim IA, Engel A, et al. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes: an Endocrine Society scientific statement. Endocr Rev. 2024;45(1):1-44. https://academic.oup.com/edrv
- Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3-126. https://pubmed.ncbi.nlm.nih.gov/12625976/
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/11836274/
- U.S. Food and Drug Administration. The FDA warns that biotin may interfere with lab tests. FDA Safety Communication. 2017. https://www.fda.gov/medical-devices/safety-communications/fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/485053
- Selmer C, Olesen JB, Hansen ML, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab. 2014;99(7):2372-2382. https://pubmed.ncbi.nlm.nih.gov/24654753/
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
- Ravaglia G, Forti P, Maioli F, et al. Increased prevalence of coeliac disease in autoimmune thyroiditis is restricted to aged patients. Exp Gerontol. 2003;38(5):589-595. https://pubmed.ncbi.nlm.nih.gov/12742537/
- Wichman J, Winther KH, Bonnema SJ, Hegedüs L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid. 2016;26(12):1681-1692. https://pubmed.ncbi.nlm.nih.gov/27702392/
- Defined by Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986;63(1):1-8. https://pubmed.ncbi.nlm.nih.gov/3711495/
- Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5:17. https://pubmed.ncbi.nlm.nih.gov/20537182/
- Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376/
- Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005;118(7):706-714. https://pubmed.ncbi.nlm.nih.gov/15989900/
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. https://pubmed.ncbi.nlm.nih.gov/26462967/